Venmax Drugs & Pharmaceuticals Inc. logo

Venmax Drugs & Pharmaceuticals Inc. (VENMAX)

Market Open
11 Aug, 22:00
MSE MSE
17. 98
+0.78
+4.5349%
141.87M Market Cap
- P/E Ratio
- Div Yield
6,258 Volume
- Eps
17.2
Previous Close
Add Transaction
Day Range
16.81 18.4
Year Range
15.56 36.96
Want to track VENMAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VENMAX trading today higher at ₹17.98, an increase of 4.5349% from yesterday's close, completing a monthly increase of 2.7429% or ₹0.48. Over the past 12 months, VENMAX stock lost -27.2065%.
VENMAX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

VENMAX Chart

Venmax Drugs & Pharmaceuticals Inc. (VENMAX) FAQ

What is the stock price today?

The current price is ₹17.98.

On which exchange is it traded?

Venmax Drugs & Pharmaceuticals Inc. is listed on MSE.

What is its stock symbol?

The ticker symbol is VENMAX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 141.87M.

Has Venmax Drugs & Pharmaceuticals Inc. ever had a stock split?

No, there has never been a stock split.

Venmax Drugs & Pharmaceuticals Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
MSE Exchange
- ISIN
India Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Venmax Drugs & Pharmaceuticals Inc. is a highly esteemed company within the pharmaceutical sector, recognized for its dedication to the discovery, development, and distribution of a wide array of medications. This company is distinguished by its unwavering commitment to providing cutting-edge healthcare solutions and high-grade pharmaceuticals designed to meet a broad spectrum of medical requirements across various therapeutic categories. Venmax's operations encompass the manufacture of both generic and branded medications, thereby guaranteeing both affordability and accessibility for consumers worldwide. In playing a pivotal role in the healthcare industry, Venmax collaborates closely with hospitals, healthcare providers, and governments, aiming to enhance patient health outcomes significantly. The company is celebrated for its intensive focus on research and development, consistently exploring innovative approaches to tackling severe health conditions with efficacious treatments. Through the integration of advanced technology and extensive clinical trials, Venmax maintains a prominent stance in the pharmaceutical market, thereby making considerable contributions to the progression of medical treatments and the enhancement of patient care on a global scale.

Products and Services

Venmax Drugs & Pharmaceuticals Inc.'s product line and services are extensive, focusing on delivering exceptional value to the healthcare sector. Here are some of their key offerings:

  • Generic Drugs

    Venmax provides a broad range of generic drugs that are bioequivalent to their branded counterparts, offering the same quality, safety, and efficacy but at a lower cost. This segment caters to the needs of consumers seeking more affordable medication options, thereby ensuring that patients across various economic backgrounds have access to essential treatments.

  • Branded Pharmaceuticals

    The company also specializes in the development and distribution of proprietary branded pharmaceuticals. These products, born out of Venmax’s rigorous research and development process, target specific therapeutic areas with innovative treatments designed to improve patient outcomes. Branded pharmaceuticals by Venmax are synonymous with quality and therapeutic efficacy, often leading the market in their respective categories.

  • Healthcare Partnerships

    Venmax actively engages in strategic partnerships with hospitals, healthcare providers, and government entities. These collaborations are aimed at ensuring the widespread availability of its pharmaceutical products, enhancing healthcare delivery, and facilitating the implementation of comprehensive, effective treatment plans for patients. Such partnerships underscore Venmax's role as a critical player in the healthcare ecosystem, dedicated to improving public health outcomes.

  • Research and Development

    The backbone of Venmax's success lies in its outstanding commitment to research and development (R&D). The company invests heavily in R&D to discover novel therapeutic agents and to develop next-generation treatments that address unmet medical needs. Through the use of cutting-edge technology and rigorous clinical trials, Venmax is at the forefront of introducing innovative treatments that can significantly improve patient care and treatment outcomes.

Contact Information

Address: Shed No.22, Plot No.84
Phone: 91 98 8530 8133